Mart Amick
Internal Medicine · Wilmington, DENPI 1942209143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,709 and has fallen 98.7% since, to $23 in 2022.
Across 171 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$281
- AbbVie$279
- Amgen$264
- Lilly USA, LLC$227
- AstraZeneca$200
- Pfizer$185
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,540100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $281 |
| AbbVie(2 entities) | 15 | $279 |
| Amgen | 15 | $264 |
| Lilly USA, LLC | 15 | $227 |
| AstraZeneca | 12 | $200 |
| Pfizer | 16 | $185 |
| Astellas Pharma US Inc | 15 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $127 |
| Merck | 6 | $96 |
| Kowa Pharmaceuticals America, Inc. | 7 | $89 |
| Johnson & Johnson | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 5 | $59 |
| Novartis | 4 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Vivus LLC | 3 | $46 |
| Amarin Pharma, Inc. | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $26 |
| CSL Behring | 1 | $25 |
| Boehringer Ingelheim | 2 | $23 |
| Adlon Therapeutics L.p. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Resmed Corp | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Digestive Care, Inc. | 1 | $14 |
How this compares
$2,548 in reported general payments places this provider in the 85th percentile of 477 internal medicine providers in Delaware.
Other internal medicine in Wilmington
- Jose CastroWilmington$27K
- Marcia Gina CastroWilmington$24K
- Robert KopeckiWilmington$15K
- Franklin AmpaduWilmington$15K
- Andrew MyersWilmington$15K
- Armand DesanctisWilmington$11K
- Carol Alvarado-BarrantesWilmington$10K
- Stuart FelzerWilmington$6K
- Terry HortonWilmington$5K
- Jerry GluckmanWilmington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.